MA 200 = $8.14 ... if this passed ... a dramatic squeeze (and new technical buyers) take in action.
Even the most sceptical AF wrote last morning :
Shareholder to me, talking up today's data PR: If this were a biotech IPO and that's all we knew, the valuation would be $700M.
Btw. $700MK = 10,15$ ... in a rush ...with no further news